Nifuroxazide-D4 is intended for use as an internal standard for the quantification of nifuroxazide by GC- or LC-MS. Nifuroxazide (
T1563) is a nitrofuran antibiotic. It is active against strains of the enteropathogenic bacteria C. jejuni,Salmonella,Y. enterocolitica,Shigella,and E. coli. It inhibits quorum sensing and virulence factor production in P. aeruginosa. Nifuroxazide (
T1563)inhibits STAT3 activity in a reporter assay and decreases viability of U266 and INA-6 myeloma cells,which have constitutive STAT3 phosphorylation,with EC50 values of approximately 4.5 µM for both. It also decreases viability,migration,and invasion of,and induces apoptosis in,MCF-7,4T1,and MDA-MB-231 breast cancer cells. Nifuroxazide (
T1563)reduces tumor growth and prevents pulmonary metastasis in a 4T1 murine mammary carcinoma model. It also reduces diarrhea,weight loss,and colon inflammation in a rat model of acetic acid-induced ulcerative colitis.